Construction, application and prospect of integrated management information system for tuberculosis prevention and control in Shanghai

doi:10.19982/j.issn.1000-6621.20240307

Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (1): 18-21.doi: 10.19982/j.issn.1000-6621.20240307

• Special Topic • Previous Articles Next Articles

Construction, application and prospect of integrated management information system for tuberculosis prevention and control in Shanghai

Rao Lixin¹, Wu Zheyuan², Chen Jing¹, Mao Dan³, Liu Xinghang³, Shen Xin⁴(), Chen Xin⁵()

¹Section of Tuberculosis Control and Prevention, Department of Tuberculosis and AIDS Control and Prevention, Shanghai Municipal Center for Disease and Prevention,Shanghai 201107,China
²Research Management Department, Shanghai Municipal Center for Disease and Prevention,Shanghai 201107,China
³Section of Standard and Project Management, Shanghai Municipal Center for Disease and Prevention,Shanghai 201107,China
⁴Department of Tuberculosis and AIDS Control and Prevention, Shanghai Municipal Center for Disease and Prevention,Shanghai 201107,China
⁵Shanghai Municipal Center for Disease and Prevention,Shanghai 201107,China

Received:2024-07-26 Online:2025-01-10 Published:2025-01-02
Contact: Shen Xin,Chen Xin E-mail:shenxin@scdc.sh.cn;chenxin@scdc.sh.cn
Supported by:
National Natural Science Foundation of China(82373650);Shanghai Three-year (2023—2025) Action Plan to Strengthen the Public Health System(GWVI-11.1-05);Top Young Talents in Shanghai 2023;Shanghai Municipal Health Commission Policy Research Project(2024HP80)

Abstract

Abstract:

Information system plays an increasingly important role in the prevention and control of infectious diseases owing to the rapid development of information technology and the widespread popularization of the internet. Shanghai Tuberculosis Management Information System has been prepared since 2010, and in 2015 it was officially put into use and accomplished data interchange with National Tuberculosis Management Information System. The authors summarized the experience and practice of tuberculosis information construction in Shanghai, comprehensively introduces the overall planning of Shanghai Tuberculosis Management Information System, reviewed the system construction, transformation and application in more than ten years, and prospects the subsequent function expansion and intelligent application of the system.

Key words: Tuberculosis, Communicable disease control, Management information system

CLC Number:

Rao Lixin, Wu Zheyuan, Chen Jing, Mao Dan, Liu Xinghang, Shen Xin, Chen Xin. Construction, application and prospect of integrated management information system for tuberculosis prevention and control in Shanghai[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 18-21. doi: 10.19982/j.issn.1000-6621.20240307

Figures/Tables 2

References 11

[1]	张胜年, 袁政安, 梅建, 等. 上海市“三位一体”结核病防治模式成效初探. 中国防痨杂志, 2007, 29(1):74-77.
[2]	梅建. 上海结核病防治工作面临新的历史转折点. 上海预防医学, 2019, 31(1):23-27.
[3]	中华人民共和国中央人民政府. 中共中央国务院印发《“健康中国2030”规划纲要》[EB/OL]. [2024-07-02]. https://www.gov.cn/xinwen/2016-10/25/content_5124174.htm.
[4]	World Health Organization. The End TB Strategy. Geneva: World Health Organization, 2015.
[5]	United Nation. Sustainable Development Goals[EB/OL]. [2024-07-02]. https://www.un.org/sustainabledevelopment/.
[6]	中华人民共和国国务院办公厅. 国务院办公厅关于推动疾病预防控制事业高质量发展的指导意见(国办发〔2023〕46号)[EB/OL]. [2024-07-02]. https://www.gov.cn/zhengce/zhengceku/202312/content_6922484.htm.
[7]	杜昕, 李涛, 李游, 等. 基于《全民健康保障工程建设规划》的新型《结核病监测信息系统》开发及验证. 中国防痨杂志, 2020, 42(7):662-666. doi:10.3969/j.issn.1000-6621.2020.07.004.
[8]	Wu Z, Lu L, Li Y, et al. Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study. Front Public Health, 2023, 11:923319. doi:10.3389/fpubh.2023.923319.
[9]	秦楠, 宁晨曦, 张祖荣, 等. 结核病患者手机应用程序督导服药的应用及其影响因素. 中国卫生资源, 2023, 26(4):358-362, 369. doi::10.13688/j.cnki.chr.2023.230133.
[10]	黄飞, 赵雁林. 加快结核病监测系统信息化建设. 中国防痨杂志, 2020, 42(7):649-652. doi:10.3969/j.issn.1000-6621.2020.07.001.
[11]	国家疾病预防控制局, 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 等. 关于印发《关于建立健全智慧化多点触发传染病监测预警体系的指导意见》的通知(国疾控监测发〔2024〕16号)[EB/OL]. [2024-10-26]. https://www.gov.cn/zhengce/zhengceku/202408/content_6971481.htm.

[1]	Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
[2]	Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
[3]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[4]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[5]	Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[8]	Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
[9]	Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
[10]	Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
[11]	Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
[12]	Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
[13]	Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497.
[14]	Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
[15]	Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.

Construction, application and prospect of integrated management information system for tuberculosis prevention and control in Shanghai

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 11

Related Articles 15

Recommended Articles

Metrics

Comments